Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220853882> ?p ?o ?g. }
- W4220853882 endingPage "e002049" @default.
- W4220853882 startingPage "e002049" @default.
- W4220853882 abstract "Evaluate the effect of upadacitinib on pain outcomes in patients with active psoriatic arthritis (PsA) or ankylosing spondylitis (AS) across 3 randomised trials (SELECT-PsA 1 and 2 for PsA; SELECT-AXIS 1 for AS).Patients were randomised to upadacitinib 15 mg once daily or placebo (all 3 studies), or adalimumab 40 mg every other week (SELECT-PsA 1 only). Pain outcomes included proportion of patients achieving ≥30%, ≥50% and ≥70% reduction from baseline in patient global assessment of pain and other end points.A higher proportion of patients receiving upadacitinib versus placebo achieved ≥30%, ≥50% and ≥70% reduction in pain end points as early as week 2; these improvements with upadacitinib were generally sustained or increased through year 1 (PsA 1/2 studies: 64%/48%, 58%/42% and 38%/22%, respectively; SELECT-AXIS 1 study: 76%, 72% and 54%). Results were similar with adalimumab in PsA 1 (59%, 49% and 32%). Patients who switched from placebo to upadacitinib 15 mg were able to reach a similar level of improvement as the continuous upadacitinib groups by year 1 (PsA 1/2 studies: 46%-60%, 35%-49% and 15%-34%; AS study: 83%, 72% and 46%). Results were similar with other pain end points.Rapid and sustained improvements in pain outcomes across several end points were consistently shown with upadacitinib over 1 year in patients with active PsA or AS who had either inadequate response to prior non-biologic or biologic disease-modifying antirheumatic drugs (PsA studies) or were biologic-naïve with inadequate response to non-steroidal anti-inflammatory drugs (AS study)." @default.
- W4220853882 created "2022-04-03" @default.
- W4220853882 creator A5009877697 @default.
- W4220853882 creator A5012348347 @default.
- W4220853882 creator A5013414260 @default.
- W4220853882 creator A5015084747 @default.
- W4220853882 creator A5028379115 @default.
- W4220853882 creator A5031269142 @default.
- W4220853882 creator A5033069279 @default.
- W4220853882 creator A5051851484 @default.
- W4220853882 creator A5054685224 @default.
- W4220853882 creator A5058876047 @default.
- W4220853882 creator A5064220409 @default.
- W4220853882 creator A5065176585 @default.
- W4220853882 creator A5070478316 @default.
- W4220853882 creator A5078634383 @default.
- W4220853882 creator A5086804517 @default.
- W4220853882 creator A5087471106 @default.
- W4220853882 date "2022-03-01" @default.
- W4220853882 modified "2023-10-12" @default.
- W4220853882 title "Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials" @default.
- W4220853882 cites W1990305566 @default.
- W4220853882 cites W2016178396 @default.
- W4220853882 cites W2072322661 @default.
- W4220853882 cites W2116858086 @default.
- W4220853882 cites W2159697181 @default.
- W4220853882 cites W2161344815 @default.
- W4220853882 cites W2336401338 @default.
- W4220853882 cites W2484940717 @default.
- W4220853882 cites W2540974094 @default.
- W4220853882 cites W2554626374 @default.
- W4220853882 cites W2572897530 @default.
- W4220853882 cites W2590526904 @default.
- W4220853882 cites W2622441786 @default.
- W4220853882 cites W2624809462 @default.
- W4220853882 cites W2625530172 @default.
- W4220853882 cites W2724955338 @default.
- W4220853882 cites W2754259943 @default.
- W4220853882 cites W2766717228 @default.
- W4220853882 cites W2766846920 @default.
- W4220853882 cites W2788592978 @default.
- W4220853882 cites W2796283304 @default.
- W4220853882 cites W2800270183 @default.
- W4220853882 cites W2800515362 @default.
- W4220853882 cites W2807366398 @default.
- W4220853882 cites W2810397534 @default.
- W4220853882 cites W2884090647 @default.
- W4220853882 cites W2887140526 @default.
- W4220853882 cites W2896559962 @default.
- W4220853882 cites W2901986848 @default.
- W4220853882 cites W2961111920 @default.
- W4220853882 cites W2969598066 @default.
- W4220853882 cites W2972010517 @default.
- W4220853882 cites W2988532979 @default.
- W4220853882 cites W3010191882 @default.
- W4220853882 cites W3027539208 @default.
- W4220853882 cites W3039392547 @default.
- W4220853882 cites W3084519990 @default.
- W4220853882 cites W3087494010 @default.
- W4220853882 cites W3098076485 @default.
- W4220853882 cites W3109739095 @default.
- W4220853882 cites W3147660541 @default.
- W4220853882 cites W3157994245 @default.
- W4220853882 cites W3159598855 @default.
- W4220853882 cites W3173474932 @default.
- W4220853882 cites W4210974969 @default.
- W4220853882 cites W4211170289 @default.
- W4220853882 cites W4211203343 @default.
- W4220853882 cites W4235489476 @default.
- W4220853882 doi "https://doi.org/10.1136/rmdopen-2021-002049" @default.
- W4220853882 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35332058" @default.
- W4220853882 hasPublicationYear "2022" @default.
- W4220853882 type Work @default.
- W4220853882 citedByCount "7" @default.
- W4220853882 countsByYear W42208538822022 @default.
- W4220853882 countsByYear W42208538822023 @default.
- W4220853882 crossrefType "journal-article" @default.
- W4220853882 hasAuthorship W4220853882A5009877697 @default.
- W4220853882 hasAuthorship W4220853882A5012348347 @default.
- W4220853882 hasAuthorship W4220853882A5013414260 @default.
- W4220853882 hasAuthorship W4220853882A5015084747 @default.
- W4220853882 hasAuthorship W4220853882A5028379115 @default.
- W4220853882 hasAuthorship W4220853882A5031269142 @default.
- W4220853882 hasAuthorship W4220853882A5033069279 @default.
- W4220853882 hasAuthorship W4220853882A5051851484 @default.
- W4220853882 hasAuthorship W4220853882A5054685224 @default.
- W4220853882 hasAuthorship W4220853882A5058876047 @default.
- W4220853882 hasAuthorship W4220853882A5064220409 @default.
- W4220853882 hasAuthorship W4220853882A5065176585 @default.
- W4220853882 hasAuthorship W4220853882A5070478316 @default.
- W4220853882 hasAuthorship W4220853882A5078634383 @default.
- W4220853882 hasAuthorship W4220853882A5086804517 @default.
- W4220853882 hasAuthorship W4220853882A5087471106 @default.
- W4220853882 hasBestOaLocation W42208538821 @default.
- W4220853882 hasConcept C126322002 @default.
- W4220853882 hasConcept C142724271 @default.
- W4220853882 hasConcept C204787440 @default.
- W4220853882 hasConcept C27081682 @default.